Physician profile
Lewis H Freed
NPI 1407842941
$996,776.82
in general payments reported to CMS, 2019-2025
42 companies · $134K in 2025
The $134K reported for 2025 was more than what 99% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $81K · 2020: $318K · 2021: $103K · 2022: $119K · 2023: $74K · 2024: $169K · 2025: $134K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $315K · Consulting Fee: $28K · Travel and Lodging: $28K · Food and Beverage: $4,572.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $314,548.91 |
| Consulting Fee | $28,396.72 |
| Travel and Lodging | $28,322.00 |
| Food and Beverage | $4,572.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trice Medical, INC. | $442,005.61 | 2022-2025 | |
| Paragon 28, INC. | $290,901.30 | 2019-2025 | Portfolio, React |
| Tenex Health INC. | $173,411.58 | 2019-2021 | |
| Wright Medical Technology, INC. | $58,065.40 | 2019-2020 | |
| Arthrex, INC. | $23,095.70 | 2019-2025 | Arthrex |
| Musculoskeletal Transplant Foundation INC. | $5,316.99 | 2021-2022 | |
| Abbott Laboratories | $1,155.59 | 2021-2025 | Proclaim |
| Impactortho, INC. | $450.89 | 2024-2025 | |
| Alafair Biosciences, INC. | $183.14 | 2025 | Versawrap |
| Stryker Corporation | $170.05 | 2022-2023 | Prostep |
| Orthofix Medical, INC. | $164.67 | 2022-2025 | Physio-Stim |
| Averitas Pharma INC. | $158.22 | 2025 | Qutenza |
| Treace Medical Concepts, INC. | $148.26 | 2022-2024 | |
| Nalu Medical, INC. | $144.82 | 2025 | Nalu Neurostimulation System |
| Boston Scientific Corporation | $135.43 | 2022 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $130.06 | 2024-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Marigen |
| Pacira Pharmaceuticals Incorporated | $121.84 | 2025 | Exparel |
| Bioventus LLC | $118.46 | 2020-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Smith+Nephew, INC. | $116.32 | 2019-2024 | Stravix Pl, Acticoat 4" X 4" |
| Exsomed Corporation | $103.61 | 2020 | |
| Biowound Solutions, INC. | $100.04 | 2025 | Bio-Connekt |
| Merck Sharp & Dohme LLC | $97.45 | 2019 | |
| Acumed LLC | $88.20 | 2022 | |
| Osteomed LLC | $79.09 | 2021 | |
| Paratek Pharmaceuticals, INC. | $63.79 | 2024-2025 | Nuzyra |
| Carbofix Orthopedics INC | $36.19 | 2025 | |
| Baxter Healthcare | $33.20 | 2025 | |
| Integra Lifesciences Corporation | $25.96 | 2019 | |
| Urgo Medical North America, LLC | $23.51 | 2025 | Urgoclean Ag |
| Amgen INC. | $21.18 | 2025 | Krystexxa |
| Surgenex LLC | $20.38 | 2025 | Ardeograft, Surmatrix, Pellograft |
| Nevro Corp. | $17.79 | 2024 | Senza |
| Lifenet Health | $17.66 | 2025 | Theragenesis Wound Matrix |
| Mimedx Group, INC. | $13.64 | 2025 | |
| Misonix INC | $13.13 | 2020 | |
| Biocomposites INC | $9.74 | 2024 | |
| Next Science LLC | $9.65 | 2023 | Blastx, Surgx, Xperience |
| Reprise Biomedical, INC. | $8.28 | 2024 | Miro3d |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$299,999.89 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lewis Freed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.